Bioinformatician, machine learner and sailor.
New York, NY
Joined April 2010
- Tweets71
- Following166
- Followers115
- Likes48
Carlos Villacorta retweeted
Are you a highly motivated, experienced bioinformatician? Come join us @CReM_Boston and lead our iPSC-focused bioinformatics core!
linkedin.com/jobs/search/?cu…
Carlos Villacorta retweeted
We are thrilled to share our latest work “Multi-Modal Profiling of Human Fetal Liver-Derived Hematopoietic Stem Cells Reveals the Molecular Signature of Engraftment Potential“ as a resource with the scientific community: biorxiv.org/content/10.1101/… 1/4
Carlos Villacorta retweeted
and a special thanks to all our wonderful collaborators @CReM_Boston @BUPulmonary @OrianShirihai @cvillamar @BUCNSB, Dr. Guttentag @VanderbiltU, Drs. Wambach and Cole @WUSTLmed, and Dr. Hamvas @NUFeinbergMed
Carlos Villacorta retweeted
Integrated transcriptomic data from iPSC-derived AT2s from @CReM_Boston and @neidl and primary human AT2s from @Tatalab_Duke infected with #SARSCoV2 into a super user-friendly interface! Great job @cvillamar! Check it out: crem.shinyapps.io/SARS-CoV-2…
Want to see how your favorite gene changes in both primary human lung AT2 cells from @Tatalab_Duke as well as iPSC-derived AT2s from @kottond after SARS-CoV-2? Check out our ShinyApp where the data sets from both our papers can be interrogated together!
crem.shinyapps.io/SARS-CoV-2…
Carlos Villacorta retweeted
All research is translational! Another example of how society’s investment in basic curiosity and basic science results in cutting edge clinical applications. To our newest Nobel Laureates, Drs. Doudna and Charpentier: we salute you @CReM_Boston
BREAKING NEWS:
The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”
Carlos Villacorta retweeted
Just out today, our latest work modeling COVID in vitro using stem cells @CellStemCell
SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response cell.com/cell-stem-cell/full…
Carlos Villacorta retweeted
A new model for SARS-CoV-2 infection in iPSC-derived human type 2 cells from @hjhjess, @kristy_abo, and @RhiannonWerder of @Kottond and @Awilsonlab labs out now in @biorxivpreprint!
Ft. @cvillamar @FinnHawkins @neidl @BUPulmonary
#COVID19 #SARSCoV2
Hot off the pre-print presses! We are pleased to announce our new human in vitro COVID-19 lung disease model: iPSC-derived human type 2 pneumocytes infected with SARS-CoV-2 -- a collaboration of @CReM_Boston @BUPulmonary and @neidl! #wearethecrem
biorxiv.org/content/10.1101/…
Carlos Villacorta retweeted
There may be no bagels, but CReMinar goes on! Fantastic work from @kristy_abo, @hjhjess, @TaylorMatte4, @cvillamar (and twitterless Martin) on modeling SARS-CoV-2 infection in iPSC-derived lung cells.
We really stress tested the Zoom chat function that’s for sure...
Carlos Villacorta retweeted
Help is on the way! When we couldn’t get our ICU patients tested for COVID @The_BMC, @DrGJMurphy and @CReM_Boston stepped in and had our backs. One of the more remarkable stories I have encountered during the pandemic. Scientists and doctors working together can solve anything!
How we turned our stem cell research center @CReM_Boston into an FDA approved #COVID19 diagnostic lab for @The_BMC in 7 days. bu.edu/articles/2020/crem-co…
Carlos Villacorta retweeted
The CReM of BU/BMC announces the release of resources and unpublished datasets to help respond to COVID-19! Check out expression levels of ACE2 and TMPRSS2 in our iPSC-derived lung lineages compared to primary lung here:
#aintnostoppingus
@CReM_Boston
bumc.bu.edu/kottonlab/covid-…
Great paper from Laertis and our second this week. Go @CReM_Boston !
Just out: Our paper on the genetic program of primordial #lung progenitors w/ @Kottond lab in @NatureComms : nature.com/articles/s41467-0… A truly multidisciplinary effort w/ researchers from @CReM_Boston , @bu_physics , @penn, @BU_Biochemistry , @CincyChildrens & @biogen
@BUPulmonary
Carlos Villacorta retweeted
Check out our brand new paper @CellStemCell Reconstructed Single-Cell Fate Trajectories
Define Lineage Plasticity Windows during
Differentiation of Human PSC-Derived Distal Lung Progenitors cell.com/action/showPdf?pii=… thanks @KaminskiMed @AlejoFraticelli @johnding86 @AnjaliJacob_
Carlos Villacorta retweeted
The Kotton Lab announces our new paper out today in Cell Stem Cell. Congrats to authors @killian_hurley, Jun Ding, Ziv Bar-Joseph and all our collaborators! @KaminskiMed @GMostoslavsky @Awilsonlab cell.com/cell-stem-cell/full…
Carlos Villacorta retweeted
Hot off the press from @AnjaliJacob_ of @kottond’s lab: a how-to on generating self-renewing iAEC2s from human pluripotent stem cells!
Featuring @cvillamar and @FinnHawkins
@BUMedicine @The_BMC @BUPulmonary @BU_MTM @BUexperts
#WeAreTheCReM
The Kotton Lab announces our new paper just out today @NatureProtocols: Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells | @CReM_Boston nature.com/articles/s41596-0…
Carlos Villacorta retweeted
The Kotton Lab’s preprint of our latest work is out today on Biorxiv from @killian_hurley: Single-cell time-series mapping of cell fate trajectories reveals an expanded developmental potential for human PSC-derived distal lung progenitors biorxiv.org/content/10.1101/…
good to know that Google and Microsoft will contribute new science metrics nature.com/news/2011/110802/…